The role of HIF-1 in hypoxic response in the skeletal muscle

Advances in Experimental Medicine and Biology

Volumn 618, Issue , 2007, Pages 229-244

  Mason, Steven ^a   Johnson, Randall S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Endurance exercise; HIF; Oxidative capacity; Skeletal muscle

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXIDOREDUCTASE; PYRUVATE DEHYDROGENASE;

AEROBIC METABOLISM; ANGIOGENESIS; CONFERENCE PAPER; ENDURANCE; ENZYME ACTIVITY; ENZYME INHIBITION; GLYCOLYSIS; LUNG GAS EXCHANGE; MUSCLE FUNCTION; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; TISSUE OXYGENATION;

MUS;

ANIMALS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MUSCLE, SKELETAL; OXYGEN; PHYSICAL CONDITIONING, ANIMAL; PHYSICAL ENDURANCE; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 50949099761     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-75434-5_18     Document Type: Conference Paper

References (85)

1. Ameln H, Gustafsson T, Sundberg CJ, Okamoto K, Jansson E, Poellinger L, and Makino Y. Physiological activation of hypoxia inducible factor-1 in human skeletal muscle. Faseb J 19: 1009-1011, 2005.
2. Argov Z, Bank WJ, Maris J, Leigh JS, Jr., and Chance B. Muscle energy metabolism in human phosphofructokinase deficiency as recorded by 31P nuclear magnetic resonance spectroscopy. Ann Neurol 22: 46-51, 1987.
3. Baar K, Song Z, Semenkovich CF, Jones TE, Han DH, Nolte LA, Ojuka EO, Chen M, and Holloszy JO. Skeletal muscle overexpression of nuclear respiratory factor 1 increases glucose transport capacity. Faseb J 17: 1666-1673, 2003.
4. Berthon PM, Howlett RA, Heigenhauser GJ, and Spriet LL. Human skeletal muscle carnitine palmitoyltransferase I activity determined in isolated intact mitochondria. J Appl Physiol 85: 148-153, 1998.
5. Brooks GA. Mammalian fuel utilization during sustained exercise. Comp Biochem Physiol B Biochem Mol Biol 120: 89-107, 1998.
6. Bruick RK, and McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294: 1337-1340, 2001.
7. Bruning JC, Michael MD, Winnay JN, Hayashi T, Horsch D, Accili D, Goodyear LJ, and Kahn CR. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2: 559-569, 1998.
8. Christ-Roberts CY, Pratipanawatr T, Pratipanawatr W, Berria R, Belfort R, Kashyap S, and Mandarino LJ. Exercise training increases glycogen synthase activity and GLUT4 expression but not insulin signaling in overweight nondiabetic and type 2 diabetic subjects. Metabolism 53: 1233-1242, 2004.
9. Cockman ME, Masson N, Mole DR, Jaakkola P, Chang GW, Clifford SC, Maher ER, Pugh CW, Ratcliffe PJ, and Maxwell PH. Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J Biol Chem 275: 25733-25741, 2000.
10. Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, Mackman N, Haase VH, Jaenisch R, Corr M, Nizet V, Firestein GS, Gerber HP, Ferrara N, and Johnson RS. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112: 645-657, 2003.
11. Dahia PL, Ross KN, Wright ME, Hayashida CY, Santagata S, Barontini M, Kung AL, Sanso G, Powers JF, Tischler AS, Hodin R, Heitritter S, Moore F, Dluhy R, Sosa JA, Ocal IT, Benn DE, Marsh DJ, Robinson BG, Schneider K, Garber J, Arum SM, Korbonits M, Grossman A, Pigny P, Toledo SP, Nose V, Li C, and Stiles CD. A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS genetics 1: 72-80, 2005.
12. Dalakas MC, Mock V, and Hawkins MJ. Fatigue: definitions, mechanisms, and paradigms for study. Semin Oncol 25: 48-53, 1998.
13. DiMauro S, Bresolin N, and Hays AP. Disorders of glycogen metabolism of muscle. CRC Crit Rev Clin Neurobiol 1: 83-116, 1984.
14. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ, and Ratcliffe PJ. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107: 43-54, 2001.
15. Esbjornsson M, Jansson E, Sundberg CJ, Sylven C, Eiken O, Nygren A, and Kaijser L. Muscle fibre types and enzyme activities after training with local leg ischaemia in man. Acta Physiol Scand 148: 233-241, 1993.
16. Fitts RH, and Holloszy JO. Lactate and contractile force in frog muscle during development of fatigue and recovery. Am J Physiol 231: 430-433, 1976.
17. Fluck M, and Hoppeler H. Molecular basis of skeletal muscle plasticity - from gene to form and function. Rev Physiol Biochem Pharmacol 146: 159-216, 2003.
18. Freyssenet DG. Energy sensing and regulation of gene expression in skeletal muscle. J Appl Physiol 2006.
19. Fueger PT, Shearer J, Krueger TM, Posey KA, Bracy DP, Heikkinen S, Laakso M, Rottman JN, and Wasserman DH. Hexokinase II protein content is a determinant of exercise endurance capacity in the mouse. The Journal of physiology 566: 533-541, 2005.
20. Gulick T, Cresci S, Caira T, Moore DD, and Kelly DP. The peroxisome proliferatoractivated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc Natl Acad Sci U S A 91: 11012-11016, 1994.
21. Haller RG, and Vissing J. Spontaneous "second wind" and glucose-induced second "second wind" in McArdle disease: oxidative mechanisms. Arch Neurol 59: 1395-1402, 2002.
22. Harms SJ, and Hickson RC. Skeletal muscle mitochondria and myoglobin, endurance, and intensity of training. J Appl Physiol 54: 798-802, 1983.
23. Hawley SA, Selbert MA, Goldstein EG, Edelman AM, Carling D, and Hardie DG. 5′-AMP activates the AMP-activated protein kinase cascade, and Ca2+/calmodulin activates the calmodulin-dependent protein kinase I cascade, via three independent mechanisms. J Biol Chem 270: 27186-27191, 1995.
24. Holloszy JO, and Coyle EF. Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. J Appl Physiol 56: 831-838, 1984.
25. Holmes BF, Sparling DP, Olson AL, Winder WW, and Dohm GL. Regulation of muscle GLUT4 enhancer factor and myocyte enhancer factor 2 by AMP-activated protein kinase. Am J Physiol Endocrinol Metab 289: E1071-1076, 2005.
26. Hoppeler H, and Fluck M. Normal mammalian skeletal muscle and its phenotypic plasticity. J Exp Biol 205: 2143-2152, 2002.
27. Hoppeler H, Howald H, Conley K, Lindstedt SL, Claassen H, Vock P, and Weibel ER. Endurance training in humans: aerobic capacity and structure of skeletal muscle. J Appl Physiol 59: 320-327, 1985.
28. Huang LE, Gu J, Schau M, and Bunn HF. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitinproteasome pathway. Proc Natl Acad Sci U S A 95: 7987-7992, 1998.
29. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS, and Kaelin WG, Jr. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292: 464-468, 2001.
30. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, and Ratcliffe PJ. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292: 468-472, 2001.
31. Jewell UR, Kvietikova I, Scheid A, Bauer C, Wenger RH, and Gassmann M. Induction of HIF-1alpha in response to hypoxia is instantaneous. Faseb J 15: 1312-1314, 2001.
32. Kaijser L, Sundberg CJ, Eiken O, Nygren A, Esbjornsson M, Sylven C, and Jansson E. Muscle oxidative capacity and work performance after training under local leg ischemia. J Appl Physiol 69: 785-787, 1990.
33. Kaushik VK, Young ME, Dean DJ, Kurowski TG, Saha AK, and Ruderman NB. Regulation of fatty acid oxidation and glucose metabolism in rat soleus muscle: effects of AICAR. Am J Physiol Endocrinol Metab 281: E335-340, 2001.
34. Keller C, Steensberg A, Pilegaard H, Osada T, Saltin B, Pedersen BK, and Neufer PD. Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content. Faseb J 15: 2748-2750, 2001.
35. Kemper WF, Lindstedt SL, Hartzler LK, Hicks JW, and Conley KE. Shaking up glycolysis: Sustained, high lactate flux during aerobic rattling. Proc Natl Acad Sci U S A 98: 723-728, 2001.
36. Kim JW, Tchernyshyov I, Semenza GL, and Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell metabolism 3: 177-185, 2006.
37. Kjaer M, Kiens B, Hargreaves M, and Richter EA. Influence of active muscle mass on glucose homeostasis during exercise in humans. J Appl Physiol 71: 552-557, 1991.
38. Kondo K, and Kaelin WG, Jr. The von Hippel-Lindau tumor suppressor gene. Exp Cell Res 264: 117-125, 2001.
39. Liao D, Corle C, Seagroves TN, and Johnson RS. Hypoxia-inducible factor-1alpha is a key regulator of metastasis in a transgenic model of cancer initiation and progression. Cancer Res 67: 563-572, 2007.
40. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN, Lowell BB, Bassel-Duby R, and Spiegelman BM. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418: 797-801, 2002.
41. Ludvik B, Mayer G, Stifter S, Putz D, Barnas U, and Graf H. Effects of dichloroacetate on exercise performance in healthy volunteers. Pflugers Arch 423: 251-254, 1993.
42. Lundby C, Gassmann M, and Pilegaard H. Regular endurance training reduces the exercise induced HIF-1alpha and HIF-2alpha mRNA expression in human skeletal muscle in normoxic conditions. Eur J Appl Physiol 1-7, 2005.
43. Lundby C, Gassmann M, and Pilegaard H. Regular endurance training reduces the exercise induced HIF-1alpha and HIF-2alpha mRNA expression in human skeletal muscle in normoxic conditions. European journal of applied physiology 96: 363-369, 2006.
44. Madan A, and Curtin PT. A 24-base-pair sequence 3′ to the human erythropoietin gene contains a hypoxia-responsive transcriptional enhancer. Proc Natl Acad Sci U S A 90: 3928-3932, 1993.
45. Mason SD, Howlett RA, Kim MJ, Olfert IM, Hogan MC, McNulty W, Hickey RP, Wagner PD, Kahn CR, Giordano FJ, and Johnson RS. Loss of skeletal muscle HIF-1alpha results in altered exercise endurance. PLoS Biol 2: e288, 2004.
46. Mu J, Barton ER, and Birnbaum MJ. Selective suppression of AMP-activated protein kinase in skeletal muscle: update on 'lazy mice'. Biochem Soc Trans 31: 236-241, 2003.
47. Murakami T, Shimomura Y, Yoshimura A, Sokabe M, and Fujitsuka N. Induction of nuclear respiratory factor-1 expression by an acute bout of exercise in rat muscle. Biochim Biophys Acta 1381: 113-122, 1998.
48. Nardone A, and Schieppati M. Shift of activity from slow to fast muscle during voluntary lengthening contractions of the triceps surae muscles in humans. The Journal of physiology 395: 363-381, 1988.
49. Narravula S, and Colgan SP. Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor alpha expression during hypoxia. J Immunol 166: 7543-7548, 2001.
50. Nau PN, Van Natta T, Ralphe JC, Teneyck CJ, Bedell KA, Caldarone CA, Segar JL, and Scholz TD. Metabolic adaptation of the fetal and postnatal ovine heart: regulatory role of hypoxia-inducible factors and nuclear respiratory factor-1. Pediatr Res 52: 269-278, 2002.
51. Olfert IM, Breen EC, Mathieu-Costello O, and Wagner PD. Chronic hypoxia attenuates resting and exercise-induced VEGF, flt-1, and flk-1 mRNA levels in skeletal muscle. J Appl Physiol 90: 1532-1538, 2001.
52. Papandreou I, Cairns RA, Fontana L, Lim AL, and Denko NC. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell metabolism 3: 187-197, 2006.
53. Pilegaard H, Ordway GA, Saltin B, and Neufer PD. Transcriptional regulation of gene expression in human skeletal muscle during recovery from exercise. Am J Physiol Endocrinol Metab 279: E806-814, 2000.
54. Pisani DF, and Dechesne CA. Skeletal muscle HIF-1alpha expression is dependent on muscle fiber type. J Gen Physiol 126: 173-178, 2005.
55. Richardson RS, Noyszewski EA, Kendrick KF, Leigh JS, and Wagner PD. Myoglobin O2 desaturation during exercise. Evidence of limited O2 transport. J Clin Invest 96: 1916-1926, 1995.
56. Rowell LB. Human cardiovascular adjustments to exercise and thermal stress. Physiol Rev 54: 75-159, 1974.
57. Russell AP, Hesselink MK, Lo SK, and Schrauwen P. Regulation of metabolic transcriptional co-activators and transcription factors with acute exercise. Faseb J 19: 986-988, 2005.
58. Ryan HE, Lo J, and Johnson RS. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. Embo J 17: 3005-3015, 1998.
59. Ryan HE, Poloni M, McNulty W, Elson D, Gassmann M, Arbeit JM, and Johnson RS. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res 60: 4010-4015, 2000.
60. Scarpulla RC. Nuclear activators and coactivators in mammalian mitochondrial biogenesis. Biochim Biophys Acta 1576: 1-14, 2002.
61. Schantz P, Henriksson J, and Jansson E. Adaptation of human skeletal muscle to endurance training of long duration. Clin Physiol 3: 141-151, 1983.
62. Schipani E, Ryan HE, Didrickson S, Kobayashi T, Knight M, and Johnson RS. Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev 15: 2865-2876, 2001.
63. Seagroves TN, Ryan HE, Lu H, Wouters BG, Knapp M, Thibault P, Laderoute K, and Johnson RS. Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells. Mol Cell Biol 21: 3436-3444, 2001.
64. Semenza G. Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol 64: 993-998, 2002.
65. Semenza GL. HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell 107: 1-3, 2001.
66. Silva JL, Giannocco G, Furuya DT, Lima GA, Moraes PA, Nachef S, Bordin S, Britto LR, Nunes MT, and Machado UF. NF-kappaB, MEF2A, MEF2D and HIF1-a involvement on insulin- and contraction-induced regulation of GLUT4 gene expression in soleus muscle. Mol Cell Endocrinol 240: 82-93, 2005.
67. Stroka DM, Burkhardt T, Desbaillets I, Wenger RH, Neil DA, Bauer C, Gassmann M, and Candinas D. HIF-1 is expressed in normoxic tissue and displays an organspecific regulation under systemic hypoxia. Faseb J 15: 2445-2453, 2001.
68. Tang K, Breen EC, Gerber HP, Ferrara NM, and Wagner PD. Capillary regression in vascular endothelial growth factor-deficient skeletal muscle. Physiol Genomics 18: 63-69, 2004.
69. Taylor EB, Lamb JD, Hurst RW, Chesser DG, Ellingson WJ, Greenwood LJ, Porter BB, Herway ST, and Winder WW. Endurance training increases skeletal muscle LKB1 and PGC-1alpha protein abundance: effects of time and intensity. American journal of physiology 289: E960-968, 2005.
70. Terada S, Goto M, Kato M, Kawanaka K, Shimokawa T, and Tabata I. Effects of low-intensity prolonged exercise on PGC-1 mRNA expression in rat epitrochlearis muscle. Biochem Biophys Res Commun 296: 350-354, 2002.
71. Thorell A, Hirshman MF, Nygren J, Jorfeldt L, Wojtaszewski JF, Dufresne SD, Horton ES, Ljungqvist O, and Goodyear LJ. Exercise and insulin cause GLUT-4 translocation in human skeletal muscle. Am J Physiol 277: E733-741, 1999.
72. Vega RB, Huss JM, and Kelly DP. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol 20: 1868-1876, 2000.
73. Vissing J, Galbo H, and Haller RG. Paradoxically enhanced glucose production during exercise in humans with blocked glycolysis caused by muscle phosphofructokinase deficiency. Neurology 47: 766-771, 1996.
74. Vogt M, Puntschart A, Geiser J, Zuleger C, Billeter R, and Hoppeler H. Molecular adaptations in human skeletal muscle to endurance training under simulated hypoxic conditions. J Appl Physiol 91: 173-182, 2001.
75. Wang GL, Jiang BH, Rue EA, and Semenza GL. Hypoxia-inducible factor 1 is a basichelix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 92: 5510-5514, 1995.
76. Wang GL, and Semenza GL. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A 90: 4304-4308, 1993.
77. Wang GL, and Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 270: 1230-1237, 1995.
78. Wang YX, Zhang CL, Yu RT, Cho HK, Nelson MC, Bayuga-Ocampo CR, Ham J, Kang H, and Evans RM. Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol 2: e294, 2004.
79. Wiesener MS, Jurgensen JS, Rosenberger C, Scholze CK, Horstrup JH, Warnecke C, Mandriota S, Bechmann I, Frei UA, Pugh CW, Ratcliffe PJ, Bachmann S, Maxwell PH, and Eckardt KU. Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. Faseb J 17: 271-273, 2003.
80. Winder WW. Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle. J Appl Physiol 91: 1017-1028, 2001.
81. Winder WW, Arogyasami J, Barton RJ, Elayan IM, and Vehrs PR. Muscle malonyl-CoA decreases during exercise. J Appl Physiol 67: 2230-2233, 1989.
82. Winder WW, Wilson HA, Hardie DG, Rasmussen BB, Hutber CA, Call GB, Clayton RD, Conley LM, Yoon S, and Zhou B. Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activated protein kinase and protein kinase A. J Appl Physiol 82: 219-225, 1997.
83. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC, and Spiegelman BM. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98: 115-124, 1999.
84. Yun Z, Maecker HL, Johnson RS, and Giaccia AJ. Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia. Dev Cell 2: 331-341, 2002.
85. Zheng D, MacLean PS, Pohnert SC, Knight JB, Olson AL, Winder WW, and Dohm GL. Regulation of muscle GLUT-4 transcription by AMP-activated protein kinase. J Appl Physiol 91: 1073-1083, 2001.